Zemer Gitai is a leader in applying quantitative and computational approaches to bacterial cell biology, host-pathogen interactions, and antibiotic development. He graduated with a bachelor’s degree from MIT in 1996, his graduate studies at UCSF in 2002, and joined the faculty of Princeton University in 2005 after completing a postdoc at Stanford University. At Princeton, Dr. Gitai was promoted to Associate Professor with tenure in 2012 and to Professor in 2015. In 2016 he became the Edwin Grant Conklin Distinguished Professor of Biology. He was also the Director of Graduate Studies for the Department of Molecular Biology from 2012-2018. Dr. Gitai’s achievements have been recognized by many prestigious awards, including the NIH Director’s Pioneer Award, the NIH New Innovator Award, the NIH Transformative Research Award, the Beckman Young Investigator Award, and the HFSP Young Investigator Award. In 2021 Dr. Gitai also founded ArrePath, a startup focused on using antibiotic discovery as a platform for advancing artificial intelligence and machine learning approaches for drug discovery.